Abstract
Calcium glucarate and N-(4-hydroxyphenyl)retinamide were evaluated individually and in combination in the diet as preventative chemical agents, by using the induction of rat mammary tumors by 7,12-dimethylbenz[a]anthracene as the test system. When tested separately over 18 weeks, optimal doses of calcium glucarate (128 mmol/kg of diet) or N-(4-hydroxyphenyl)retinamide (1.5 mmol/kg of diet) administered daily inhibited tumor incidence by 50% or 57% and tumor multiplicity by 50% or 65%, respectively. Suboptimal doses of calcium glucarate (32 mmol/kg) and of N-(4-hydroxyphenyl)retinamide (0.75 mmol/kg) inhibited tumor incidence by 15% and 5% but had no inhibitory effect on tumor multiplicity. In contrast, the combination of calcium glucarate (32 mmol/kg) and N-(4-hydroxyphenyl)retinamide (0.75 mmol/kg) inhibited tumor incidence and tumor multiplicity by 50%. Similar synergism was observed with the combination of calcium glucarate (64 mmol/kg) and N-(4-hydroxyphenyl)retinamide (0.75 mmol/kg), the inhibition being 55-60%. HPLC analysis of the bile of female rats injected intraperitoneally with a single dose of the retinamide [60 mg/kg (body weight)] showed that the excretion of the retinamide and its glucuronide were markedly suppressed by pretreatment with an oral dose of calcium glucarate [4.5 mmol/kg (body weight)].
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abou-Issa H., Duruibe V. A. Anticarcinogenic effect of retinoids on 7,12-dimethylbenz(a)anthracene-induced mammary tumor induction, and its relationship to cyclic AMP-dependent protein kinase. Biochem Biophys Res Commun. 1986 Feb 26;135(1):116–123. doi: 10.1016/0006-291x(86)90950-2. [DOI] [PubMed] [Google Scholar]
- Dickens M. S., Custer R. P., Sorof S. Retinoid prevents mammary gland transformation by carcinogenic hydrocarbon in whole-organ culture. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5891–5895. doi: 10.1073/pnas.76.11.5891. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dwivedi C., Downie A. A., Webb T. E. Net glucuronidation in different rat strains: importance of microsomal beta-glucuronidase. FASEB J. 1987 Oct;1(4):303–307. doi: 10.1096/fasebj.1.4.3115856. [DOI] [PubMed] [Google Scholar]
- Enderlin F. E., Honohan T. Long term bile collection in the rat. Lab Anim Sci. 1977 Aug;27(4):490–493. [PubMed] [Google Scholar]
- Gallup J. M., Barua A. B., Furr H. C., Olson J. A. Effects of retinoid beta-glucuronides and N-retinoyl amines on the differentiation of HL-60 cells in vitro. Proc Soc Exp Biol Med. 1987 Dec;186(3):269–274. doi: 10.3181/00379727-186-42612. [DOI] [PubMed] [Google Scholar]
- Grubbs C. J., Moon R. C., Sporn M. B., Newton D. L. Inhibition of mammary cancer by retinyl methyl ether. Cancer Res. 1977 Feb;37(2):599–602. [PubMed] [Google Scholar]
- McCormick D. L., Burns F. J., Albert R. E. Inhibition of benz[a]pyrene-induced mammary carcinogenesis by retinyl acetate. J Natl Cancer Inst. 1981 Mar;66(3):559–564. [PubMed] [Google Scholar]
- McCormick D. L., Burns F. J., Albert R. E. Inhibition of rat mammary carcinogenesis by short dietary exposure to retinyl acetate. Cancer Res. 1980 Apr;40(4):1140–1143. [PubMed] [Google Scholar]
- Moon R. C., Grubbs C. J., Sporn M. B., Goodman D. G. Retinyl acetate inhibits mammary carcinogenesis induced by N-methyl-N-nitrosourea. Nature. 1977 Jun 16;267(5612):620–621. doi: 10.1038/267620a0. [DOI] [PubMed] [Google Scholar]
- Moon R. C., Grubbs C. J., Sporn M. B. Inhibition of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis by retinyl acetate. Cancer Res. 1976 Jul;36(7 Pt 2):2626–2630. [PubMed] [Google Scholar]
- Moon R. C., Thompson H. J., Becci P. J., Grubbs C. J., Gander R. J., Newton D. L., Smith J. M., Phillips S. L., Henderson W. R., Mullen L. T. N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res. 1979 Apr;39(4):1339–1346. [PubMed] [Google Scholar]
- Silva D. P., Jr, Valliere C. R., DeLuca H. F. Lack of biological activity of physiological metabolites of all-trans-retinoic acid on vaginal epithelial differentiation. Arch Biochem Biophys. 1987 Dec;259(2):391–401. doi: 10.1016/0003-9861(87)90505-4. [DOI] [PubMed] [Google Scholar]
- Silverman J., Katayama S., Radok P., Levenstein M. J., Weisburger J. H. Effect of short-term administration of N-(4-hydroxyphenyl)-all-trans-retinamide on chemically induced mammary tumors. Nutr Cancer. 1983;4(3):186–191. [PubMed] [Google Scholar]
- Swanson B. N., Newton D. L., Roller P. P., Sporn M. B. Biotransformation and biological activity of N-(4-hydroxyphenyl)retinamide derivatives in rodents. J Pharmacol Exp Ther. 1981 Dec;219(3):632–637. [PubMed] [Google Scholar]
- Walaszek Z., Hanausek-Walaszek M., Minton J. P., Webb T. E. Dietary glucarate as anti-promoter of 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis. Carcinogenesis. 1986 Sep;7(9):1463–1466. doi: 10.1093/carcin/7.9.1463. [DOI] [PubMed] [Google Scholar]
- Walaszek Z., Hanausek-Walaszek M., Webb T. E. Dietary glucarate-mediated reduction of sensitivity of murine strains to chemical carcinogenesis. Cancer Lett. 1986 Oct;33(1):25–32. doi: 10.1016/0304-3835(86)90098-4. [DOI] [PubMed] [Google Scholar]
- Zile M. H., Cullum M. E., Simpson R. U., Barua A. B., Swartz D. A. Induction of differentiation of human promyelocytic leukemia cell line HL-60 by retinoyl glucuronide, a biologically active metabolite of vitamin A. Proc Natl Acad Sci U S A. 1987 Apr;84(8):2208–2212. doi: 10.1073/pnas.84.8.2208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zile M. H., Inhorn R. C., DeLuca H. F. Metabolism in vivo of all-trans-retinoic acid. Biosynthesis of 13-cis-retinoic acid and all-trans- and 13-cis-retinoyl glucuronides in the intestinal mucosa of the rat. J Biol Chem. 1982 Apr 10;257(7):3544–3550. [PubMed] [Google Scholar]
